期刊文献+

HDAC1蛋白在乳腺癌中的表达及临床意义及与ER、PR的关系

Expression of histone deacetylase1 in breast carcinoma and its clinical significance
原文传递
导出
摘要 目的:探讨乳腺癌组织中组蛋白去乙酰化酶1(HDAC1)的表达及临床意义。方法:应用免疫组织化学SP法检测78例乳腺癌组织和20例癌旁组织中HDAC1蛋白的表达情况并分析其与ER、PR之间的关系。结果:(1)HDAC1蛋白在78例乳腺癌中的阳性表达率为78.2%(61/78),在癌旁组织中的阳性表达率为5%(1/20),两组差异有统计学意义(P<0.01)(2)乳腺癌组织中的HDAC1蛋白在ER或PR阴性乳腺癌组织中的表达分别高于其在ER或PR阳性乳腺癌组织中的表达(P<0.01)结论:乳腺癌组织中的HDAC1蛋白过度表达与肿瘤发生发展密切相关。 To investigate the expressions of HDAC1 protein and its clinical significance in the breast carcinoma tissue.Methods:The expression of HDAC1 protein was determined by immunohistochemistry with SP system.Its correlation to estrogen receptor(ER) and progesterone receptor(PR) was analyzed.Results:(1)The positive rate of HDAC1 protein was 78.2% in breast carcinoma,which was 5% in noncancerous tissue group.There were significant differences between them(P0.01).(2)The expression of HDAC1 had negative correlation to ER and PR.Conclusion:The overexpression of HDAC1 protein closely correlated with the tumor carcinogenesis.
出处 《现代生物医学进展》 CAS 2011年第3期541-545,共5页 Progress in Modern Biomedicine
关键词 乳腺肿瘤 组蛋白去乙酰化酶 免疫组织化学法 Breast neoplasms Histone deacetylases Immunohistochemistry
  • 相关文献

参考文献14

  • 1Taunton J, Hassig CA,Schreiber SL. A mamm histone deacetylase related to the yeast transcriptiregulator Rpd3p [J]. Science, 1996, 272 (5260):408-411.
  • 2Fraga M F, Esteller M.Towards the human cancer epigenome:a first draft ofhistone modifications [J]. Cell Cycle, 2005,4(10): 1377-1381.
  • 3Mizzen CA, Allice CD, et al. Cell Linking histone acetylation to transcriptional regulation Mlo Life Sei, 1998;54(1):6-20.
  • 4Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise ofepigenetic (and more) treatments for cancer [J]. Nat IRev Cancer, 2006,6(1):38-51.
  • 5Smith KT, Workman JL. Histone deacetylase inhibitors: anticancer compounds[J]. Int J Biochem Cell Biol, 2009,41(1):21-25.
  • 6Luczak MW, Jagodzinski PP. The role of DNA methylation in cancer development[J]. Folia Histochem Cytobiol, 2006,44(3): 143-154.
  • 7Mahlknecht U, Hoelzer D. Histone acetylation modifiers in the patho genesis of malignant disease[J]. Mol Med, 2000,6(8):623-644.
  • 8Kouzarides T. Histone acetylases and deacetylases in cell proliferation [J]. Curr Opin Genet Dev, 1999, 9:40-48.
  • 9Weidle U H, Grossmann A. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticandcer treatment, Anticancer IRes, 2000,20:1471-1486.
  • 10Glozak MA, Sengupta N, Zhang X, et al. Acety lation and deacetylation of non-histone proteins. Gene 2005 Dec 19;363:15-23.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部